Bio

Has been associated with Merck and Company for 28 years. Experienced in CMC and Drug Product Development for vaccines and biologics. Executive Director associated with 50+ direct reports and department responsible for vaccine DP pipeline, novel technologies and innovation for drug delivery. Worked extensively in both early and late stage development on programs and involved in technology transfer. I have been involved with management of group members for more than 18 years. Specialties: Lyophilization development, live virus vaccine development, technology transfer, early stage and late stage TP development, adjuvant and conjugated vaccines, novel technologies development for both drug delivery (i.e., ID, MAPs, Controlled Release) and drying technologies.